Detection of equine herpesvirus 3 in equine skin lesions by polymerase chain reaction
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Abstract. During a recent breeding season, ulcerative, pustular skin lesions were observed on the external genitalia of 2 mares and 1 stallion within a small herd. Based on the location and description of the skin lesions plus the clinical history, equine coital exanthema, caused by equine herpesvirus 3 (EHV3), was the primary differential diagnosis. Scrapings of skin lesions from the perineum of 2 mares were submitted for diagnostic evaluation. Virus isolation was attempted by inoculation of several cell lines of equine origin, but no cytopathic agent was detected. The skin scrapings were processed for DNA extraction, and polymerase chain reaction (PCR) amplification was performed for herpesvirus DNA polymerase and DNA-packaging protein (terminase) genes using nested, degenerate primers targeted to conserved regions of the herpesvirus genome. Products of the expected sizes were generated for both assays, and subsequent nucleotide sequencing of the amplification products established that EHV3 had been detected in DNA extracted from the skin lesions. Detection of EHV3 was confirmed using an EHV3-specific PCR assay targeted to the gC gene. Using the novel EHV3 nucleotide sequence identified in this report, a sensitive and specific PCR assay targeted to the highly conserved DNA polymerase gene was developed.
During the 2002 breeding season, in which mares were serviced by live-cover, superficial skin lesions were observed on the external genitalia of 2 mares and 1 stallion within a small herd. At presentation, large (up to 2-5 cm), coalescing skin lesions were observed in the perineum of the 2 mares ( Fig. 1 ) and on the shaft of the stallion's penis. The ulcerated lesions were accompanied by a serous, slightly purulent exudate. Peripheral to the main lesions, raised and firm nodules were frequently noted, as were small, early erosions. Concurrent with the observation of superficial lesions in the perineum of 2 mares within the herd, tail-rubbing resulting in significant alopecia at the base of the tail was observed in both animals. No other clinical abnormalities were noted in any of the horses within the herd. Based on the description and location of the lesions as well as the clinical history of sexual activity among the affected horses, equine coital exanthema, caused by equine herpesvirus 3 (EHV3), was the primary differential diagnosis for these cases. 20 Scrapings of skin lesions from the perineum of the 2 mares were submitted to the University of Missouri's Veterinary Medical Diagnostic Laboratory (Columbia, MO) for testing. The samples arrived at the laboratory in severely desiccated condition. Samples from both mares were divided into 2 portions, which were subsequently processed for DNA extraction or virus isolation. Skin scraping samples for virus isolation were rehydrated in 1.0 ml cell culture media (Dulbecco modified Eagle medium containing 10% fetal bovine serum, 0.5 mg/ml gentamycin, and 2.5 g/ml amphotericin B), and a suspension was prepared by homogenization of the sample in a microcentrifuge tube with a sterile, disposable pestle. a The suspension was centrifuged at 6,000 ϫ g for 10 minutes, and the supernatant was filtered through a 0.45-m syringe filter.
The filtrate was adsorbed onto rabbit kidney-13 cells (RK-13), primary equine kidney cells, or primary equine dermal cells (0.1 ml/well of a 24-well plate) for 60-90 minutes at 37 C, 5% CO 2 in a humidified chamber, after which the inoculum was removed and replaced with cell culture media. Cells were maintained under standard conditions for 7 days and observed daily for the presence of viral-induced cytopathic effect. After 7 days the inoculated cells were frozen at Ϫ80 C. After thawing, 20% of the lysate from each well was passaged onto a well of fresh cells and observed for an additional 10 days. Viral-induced cytopathic effect was not detected in any of the inoculated cells after either the initial or the first passage in cell culture. Because of the condition of the samples and the slightly purulent nature of the exudate, bacterial culture was not attempted.
Samples for DNA extraction were rehydrated in 1.0 ml sterile phosphate-buffered saline (pH 7.4), and homogenization was performed as described above. A portion of the resulting suspension (0.2 ml) was digested with Proteinase K b in Buffer ATL b for 6 hours at 55 C. Extractions of DNA were performed using the QIAamp DNA mini kit b according to the manufacturer's instructions. The DNA was stored at Ϫ80 C until it was used as template for polymerase chain reaction (PCR) amplification. Amplification of a region of the herpesvirus DNA polymerase gene or DNApackaging protein (terminase) gene was performed with nested, degenerate primers targeted to conserved regions of the herpesvirus genome, 12,25 using previously described methods. 15, 16 First-round amplification of the DNA polymerase gene fragment was performed with forward primers DFA (5Ј-GAYTTYGCNA-GYYTNTAYCC-3Ј) and ILK (5Ј-TCCTGGACA-AGCAGCARNYSGCNMTNAA-3Ј) and reverse primer KG1 (5Ј-GTCTTGCTCACCAGNTCNACNC-CYTT-3Ј), and second-round amplification was performed with forward primer TGV (5Ј-TGTA-ACTCGGTGTAYGGNTTYACNGGNGT-3Ј) and reverse primer IYG (5Ј-CACAGAGTCCGTRTCNC-CRTADAT-3Ј). First-round amplification of the DNA-packaging protein gene fragment was performed with forward primer A2 (5Ј-TTGTGGACGA-GRSNMAYTTYAT-3Ј) and reverse primer B1 (5Ј-ACAGCCACGCCNGTNCCNGANGC-3Ј), and second-round amplification was performed with forward primer A3 (5Ј-GCAAGATCATNTTYRTNTCNTC-3Ј) and reverse primer B2 (5Ј-TGTTGGTCGTRWANG CNGGRTC-3Ј). After second-round amplification of the DNA polymerase gene, 2 products (approximately 225 and 440 bp) were observed. A single amplification product of approximately 415 bp was observed after the second-round reaction of the DNA-packaging protein gene. Amplification products were visualized in a 2% agarose, 1ϫ Tris-acetar EDTA (TAE) gel by ethidium bromide staining and ultraviolet transillumination. 22 Negative-control reactions, in which DNA extracted from normal (unaffected) horse tissues was added as template to the PCR reaction mixture, did not produce a product for either amplification.
Nucleotide sequencing of the DNA polymerase and DNA-packaging gene amplification products was performed to identify the specific herpesvirus detected. Amplification products were excised from the agarose gel and purified with the Qiaex II gel extraction kit. b Purified products were sequenced directly using the herpesvirus PCR primers. Nucleotide sequence analysis, performed with LaserGene version 5.0 c and BLAST 2 software, demonstrated that the 225-bp DNA polymerase gene fragment was an amplification product of the TGV and IYG primers 25 and the 440-bp fragment was a product of the TGV and KG1 primers. 25 A 390-bp product (excluding the primer sequenc-es) was used for subsequent nucleotide sequence analyses of the DNA polymerase gene fragment, and a 373-bp product (excluding the primer sequences) was used for subsequent nucleotide sequence analyses of the DNA-packaging protein gene fragment. The novel nucleotide and deduced amino acid sequence of both gene fragments were deposited in the National Center for Biotechnology Information database and assigned GenBank accession numbers AF514778 (DNA-packaging protein gene) and AF514779 (DNA polymerase gene).
Comparison of the 390-bp DNA polymerase gene fragment with those of the public domain database by BLAST 2 analysis demonstrated that the 5Ј 175 bases of this fragment were 100% identical to the sequence previously published for EHV3, 8 thus establishing the identity of the detected herpesvirus as EHV3. Other nucleotide sequences with significant similarity scores were from a large number of alphaherpesviruses, with Figure 3 . A phylogenetic tree for the DNA polymerase proteins of representative alpha-, beta-, and gammaherpesviruses plus EHV3 (shown in bold). The unrooted tree was generated using the distance matrix program NEIGHBOR with the jumble option evoked, and distance values were calculated using the PROTDIST program with the Dayhoff PAM matrix. 9 The branch lengths represent relative genetic distances. The numbers at the branch nodes indicate bootstrap values 10 based on 100 resamplings of the original data set. The resulting phylogenetic tree was displayed using TREEVIEW. 19 The herpesviruses used for comparison were AtHV2 sequences of equine herpesvirus 1 (EHV1) 23 and equine herpesvirus 4 (EHV4) 24 demonstrating the greatest similarity. Alignment of the DNA polymerase gene fragments of EHV3, EHV1, and EHV4 ( Fig. 2A ) demonstrated that the nucleotide sequence of EHV3 was 76.1% identical to that of EHV1 and 71.0% identical to that of EHV4. Over the same region of the DNA polymerase gene, the nucleotide sequence of EHV1 was 83% identical to that of EHV4. Phylogenetic analysis of the DNA polymerase gene fragment confirmed that EHV3 was closely related to, although distinct from, EHV1 and EHV4 (Fig. 3) .
Comparison of the 373-bp DNA-packaging protein gene fragment with those of the public domain databases by BLAST 2 analysis demonstrated that this nucleotide sequence was novel, although similar to that of a large number of alphaherpesviruses, with sequences of EHV1 23 and EHV4 24 demonstrating the greatest similarity. Alignment of the nucleotide sequence of DNA-packaging protein gene fragments of EHV3, EHV1, and EHV4 (Fig. 2B ) demonstrated that the sequence of EHV3 was 78.0% identical to that of EHV1 and 74.7% identical to that of EHV4. Over the same region of the DNA-packaging protein gene, the nucle- otide sequence of EHV1 was 87.6% identical to that of EHV4.
To confirm the detection of EHV3 in the skin lesions, PCR amplification of DNA extracted from the skin lesions was performed with oligonucleotide primers specific for the gC gene of EHV3, 13 as previously reported. 7 Amplification products of the predicted 520bp size were detected when DNA extracted from both samples was used as template. Although amplification of gC detected EHV3 in samples from the cases reported herein, as well as those tested in the initial validation of this assay, 7 this region of the genome may not be the optimal target for diagnostic PCR detection of EHV3. The nonessential membrane glycoprotein gC 21 demonstrates sequence variation in other alphaherpesviruses. 5, 14 Furthermore, antigenic drift may occur as a result of immunological pressure because gC is a major target of the humoral immune response in the closely related alphaherpesvirus EHV1 1 and plays a role in immune evasion of herpes simplex virus type 1. 17 To provide an alternative target for PCR detection of EHV3, an assay was developed based on the sequence of the DNA polymerase gene fragment reported herein. Degenerate primers targeting the DNA polymerase gene have been used for PCR amplification of a broad range of alpha-, beta-, and gammaherpesviruses, 25 suggesting that this is a broadly conserved herpesvirus gene. A novel PCR assay for specific amplification of the EHV3 DNA polymerase gene was performed with a forward (5Ј-GAGCTCCTTGAGGCCAACT-3Ј) and a reverse (5Ј-TTGAATAGGTCGCCGGAGA-3Ј) primer, which produced a 179-bp product when DNA extracted from the skin lesions was used as template ( Fig. 4) . Amplification of serial 10-fold dilutions of DNA extracted from the skin lesions demonstrated that the analytical sensitivity of the EHV3 DNA polymerase assay was slightly greater than the EHV3 gC-targeted PCR assay 7 (Fig. 4) . When genomic DNA of the alphaherpesviruses EHV1, EHV4, feline herpesvirus 1, and bovine herpesvirus 1 was added to the EHV3 DNA polymerase assay, no amplification products were detected (data not shown). Furthermore, when DNA extracted from normal (unaffected) horse tissues was added as template to the PCR reaction mixture, no amplification products were detected ( Fig. 4) , indicating that the assay was specific for EHV3.
Equine herpesvirus 3 is the etiologic agent of equine coital exanthema. 4, 18 This venereally transmitted disease normally has an acute, mild clinical course characterized by the formation of pustular and ulcerative lesions on the external genitalia of both mares and stallions. 3 Uncomplicated skin lesions typically heal rapidly, although white depigmentation spots are often present at the site of lesions for the life of the horse, 4 as was observed in all 3 affected animals in this case. Equine herpesvirus 3 can cause subclinical respiratory infection in young horses 18 and has been isolated from vesicular lesions on the muzzles of foal in contact with infected mares. 6 Equine herpesvirus 3 has also been shown to be potentially abortigenic through experimental in utero inoculation of a pregnant mare. 11 In summary, this report demonstrates the diagnostic usefulness of degenerate herpesvirus PCR amplification followed by nucleotide sequencing for detection of herpesviruses. Molecular diagnostic techniques were required to detect a potential pathogen in these cases because desiccation of the samples may have inactivated any viable virus present, leading to the negative virus isolation results. In the course of establishing a probable diagnosis for the skin lesions, novel gene sequences for EHV3 were identified. Using the novel EHV3 sequences reported herein, a sensitive and specific PCR assay was developed to amplify a region of the highly conserved DNA polymerase gene.
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